Items Tagged ‘MOG antibody’
December 21, 2018 · Leave a Comment
MOG antibody-associated spinal cord inflammation can mimic acute flaccid myelitis
By Advancing the Science contributor 
Mayo Clinic researchers report that spinal cord inflammation associated with an antibody to myelin oligodendrocyte glycoprotein can mimic acute flaccid myelitis, a rare but serious disease linked to certain viruses that particularly affects children and can result in paralysis. The researchers show that detecting the MOG antibody has important treatment and prognostic implications. The findings […]
View full entry Comment on this
Tags: acute flaccid myelitis, Divyanshu Dubey, Eoin Flanagan, MOG antibody, neurology, pathology, radiology, transverse myelitis
November 8, 2018 · Leave a Comment
MS or not MS? Mayo Clinic Neuroimmunology Lab answers the question
By Advancing the Science contributor
In 2017, Mayo Clinic launched a first-in-the-U.S. clinical test to help patients with some autoimmune disorders get the right diagnosis faster. The test defines a new form of inflammatory demyelinating disease, myelin oligodendrocyte glycoprotein (MOG) autoimmunity, which is distinct from multiple sclerosis (MS), with which it is commonly confused. The test uses live cells to […]
View full entry Comment on this
Tags: acute flaccid myelitis, Andrew McKeon, biomarkers, Department of Laboratory Medicine and Pathology, MOG antibody, multiple sclerosis, neuroimmunology, neurology, Sean Pittock, transverse myelitis, Vanda Lennon
December 6, 2017 · Leave a Comment
Research Roundup–November 2017
The Research Roundup is a compilation of research news releases from Mayo Clinic during the last month. You can read the brief summaries in this post, or click through for the full news release and related content. Thanks for visiting Advancing the Science! Research finds hot flashes, night sweats connected to obstructive sleep apnea risk […]
View full entry Comment on this
Tags: anticoagulant, atrial fibrillation, cardiology, Center for Individualized Medicine, clinical trials, J. William Charboneau, Joseph Grande, menopause, MOG antibody, neurology, prostate cancer, research education